Management of Depression in Primary Care

Not Applicable

Completed

• Conditions: Depression
• Interventions: Behavioral: Structured patient-centered follow up of depression

• Registration Number: NCT01402206
• Lead Sponsor: Göteborg University

Brief Summary

Most people in Sweden with mild to moderate depression are treated in primary care, but follow-up is unstructured, and we know little about whether structured, follow-up would affect the prognosis for depression and working life. The purpose of this study is to determine the effectiveness of regular, structured, patient-centered visits on mild to moderate depression.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-03
• Study First Submitted: 2011-06-27
• Study First Submitted QC: 2011-07-25
• Study First Posted: 2011-07-26
• Primary Completion: 2013-12
• Study Completion: 2014-12
• Status Verified: 2016-08
• Last Update Submitted: 2016-08-15
• Last Update Posted: 2016-08-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 258

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Structured patient visits	Structured patient-centered follow up of depression	Participants in the intervention group visit their general practitioner at baseline and 4, 8, and 12 weeks. At each visit, participants complete MADRS-s for the assessment of depression severity and discuss the results with their GP in a patient-centered consultation.
Treatment as usual	Structured patient-centered follow up of depression	The control group receives treatment as usual by general practitioner (no intervention).

Primary Outcome Measures

Name	Time	Method
Change in Depressive symptoms	3, 6 and 12 months.	Depressive symptoms will be assessed using the Beck Depression Inventory (BDI-II), a self-administered questionnaire that measures the symptoms and severity of the depression.

Secondary Outcome Measures

Name	Time	Method
Prescriptions for antidepressants	12-month follow-up period	Information on Antidepressant use will be collected from patient records from start of the study and the 12-month follow-up period
Change in Quality of life	3, 6 and 12 months	Each patient's quality of life will be assessed using the EuroQoL-5D questionnaire that measures five dimensions of quality of life
Change in Activity/work ability	12-month follow-up period	Will be measured by Work Ability Index (WAI) and the Karaseks Job Strain Model Questionnaire. The Work Ability Index is used for evaluating people's work capacity and Karaseks Job Strain Model Questionnaire is used for evaluating Demands-Control in work place
sick-listing data	12 month follow up	Data on sick-listing is derived from primary care record fom baseline to 3 months follow up and from patient interview from 3 to 12 months

Trial Locations

Locations (1)

University of Gothenburg; 🇸🇪 Gothenburg, Sweden